Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson crawled date : 2022 - 02 - 28 save search
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
Published: 2022-02-28 (Crawled : 22:00) - biospace.com/
TAK | $13.235 0.42% 710K
|
Health Technology
|
| O: 0.54%
H: 1.66%
C: 1.13%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
ARCT 4 | $30.01 2.39% 110K
|
Health Technology
|
| O: -0.93%
H: 3.16%
C: 2.35%
ces therapeutics
Bavarian Nordic to Host Full Year 2021 Results Conference Call
Published: 2022-02-28 (Crawled : 20:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
conference results
Warm Autoimmune Hemolytic Anemia Market is Expected to Witness Growth at an Accelerated CAGR of 14.7% in the 7MM for the Study Period 2018-30, Assesses DelveInsight
Published: 2022-02-28 (Crawled : 16:00) - prnewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
INCY | $53.88 0.84% 230K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
anemia cel growth
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | $46.19 0.57% 580K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Atopic Dermatitis
Published: 2022-02-28 (Crawled : 14:30) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
lnk0100 als atopic dermatitis ces dermatitis derm 100
Proud to support the EcoBeautyScore Consortium
Published: 2022-02-28 (Crawled : 13:00) - capgemini.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
Judge Approves J&J’s Texas Two-Step Plan to Enable "Expeditious" Compensation
Published: 2022-02-28 (Crawled : 13:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
Sinus Dilation Devices Market size worth $ 3.8 Billion, Globally, by 2028 at 8.32% CAGR: Verified Market Research®
Published: 2022-02-28 (Crawled : 10:00) - prnewswire.com
MDT | $79.3 -1.16% 2.4M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
research ces device
Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead of Phase 3 Trial
Published: 2022-02-28 (Crawled : 07:00) - globenewswire.com
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
covid-19 phase 2 trial covid report positive phase 2 results results vaccine phase 3
Janssen is Taking a Big Swing at Autoantibody-Driven Diseases
Published: 2022-02-28 (Crawled : 06:00) - biospace.com/
JNJ | $144.56 -2.05% 4.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
disease antibody
Gainers vs Losers
| 51% | 49% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
PRSO | $1.99 56.69% 52M
|
Manufacturing
PALI | $6.5 56.25% 22M
|
Manufacturing
JAGX | $0.1767 48.74% 430M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
DYNT | $0.5255 41.87% 18M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
MCBC | $13.795 38.92% 820K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.